Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Marian Kalocsay Image

      Marian Kalocsay, Ph.D.

      Department of Experimental Radiation Oncology, Division of Radiation Oncology

      Present Title & Affiliation

      Primary Appointment

      Assistant Professor, Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Assistant Professor, Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Research Interests

      We leverage proximity-proteomics and highly advanced mass spectrometry (MS) to study dynamics and aberrations of signaling processes in the context of immune checkpoints, pushing the envelope of existing MS technology. Through our innovative approaches we hope to elucidate ligand-specific differential immune signaling and decode differential phosphorylation in checkpoint signaling with the goal to ultimately better understand how the tumor micro-environment modulates receptor signaling.

       

      Education & Training

      Degree-Granting Education

      2009LMU University of Munich and Max-Planck Institute of Biochemistry, Munich, DE, Cell Biology, Ph.D
      2001University of Hannover, Hannover, DE, Biochemistry, Dipl

      Postgraduate Training

      2015-2017Research Fellowship, Mass Spectrometry, Harvard Medical School, Boston, Massachusetts
      2012-2015Research Fellowship, Chromatin Biology and Mass Spectrometry, Harvard Medical School, Boston, Massachusetts
      2011-2012Research Fellowship, European Molecular Biology Organization (EMBO), Harvard Medical School, Boston, Massachusetts
      2010-2010Research Fellowship, Molecular Biology, Max-Planck Institute of Biochemistry, Munich

      Experience & Service

      Faculty Academic Appointments

      Instructor, Systems Biology, Harvard Medical School, Boston, MA, 2017 - 2022

      Other Professional Positions

      Director Proteomics, Harvard Medical School, Boston, MA, 2017 - 2022

      Associated Senior Research Scientist, Harvard Medical School, Boston, MA, 2016 - 2022

      Honors & Awards

      20202020 HUPO Early Career Researcher Competition, HUPO

      Professional Memberships

      American Society for Mass Spectrometry

      2015 - Present

      Human Proteome Organization

      2015 - Present

      Grant & Contract Support

      Date: 2022 - 2027
      Title:CPRIT Recruitment of First-Time, Tenure-Track Faculty Members
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:PI
      ID:RR220032
      Date: 2022 - 2025
      Title:UT System Rising STARs Award for Dr. Marian Kalocsay
      Funding Source:University of Texas
      Role:PI

      Selected Publications

      Peer-Reviewed Articles

      1. McVeigh, BM, De Jesús-Pérez, JJ, Siepe, D, Gogoi, P, Mageswaran, SK, Kalocsay, M, Mihelc, E, Moiseenkova-Bell, V. Visualization of lysosomal membrane proteins by cryo electron tomography. Nature communications 16(1), 2025. e-Pub 2025. PMID: 41107240.
      2. Deng X, Bradshaw GA, Kalocsay M, Mitchison T. Tubulin regulates stability and localization of STMN2 by binding preferentially to its soluble form. J Cell Biol 224(12), 2025. e-Pub 2025. PMID: 41171096.
      3. Das LT, Malvezzi M, Gade A, Matsui M, McKay M, Wei EQ, Zelich MJ, Mazdisnian K, Kushner J, Chen BX, DiStefano I, Roybal D, Yang L, Stoll L, Lo JC, Kalocsay M, Akar FG, Marx SO, Pitt GS. FGF13 Regulates VGSC-Independent Cardiomyocyte Impulse Propagation via Cx43 Trafficking. Circ Res, 2025. e-Pub 2025. PMID: 41200819.
      4. Psenakova K, Parhad SS, Paulo JA, Liu X, Patterson EF, Watson R, Cheek MA, Keogh MC, Kalocsay M, Gygi SP, Farnung L, Moazed D. Catalytic pocket of Clr4 (Suv39h) methyltransferase serves as a substrate receptor for Cullin 4-dependent histone H3 ubiquitination. bioRxiv, 2025. e-Pub 2025. PMID: 40909655.
      5. Das T, Bradshaw GA, Hyer J, Masek M, Kuo YM, Bachmann-Gagescu R, Kalocsay M, Nachury MV. BBSome-Mediated Clearance of Ubiquitinated IMPG2 Defines a Constitutive Ciliary Retrieval Pathway in Photoreceptors. bioRxiv, 2025. e-Pub 2025. PMID: 40766594.
      6. Van Itallie E, Sonnett M, Kalocsay M, Wuhr M, Peshkin L, Kirschner MW. Transitions in the proteome and phospho-proteome during Xenopus laevis development. Dev Biol 525:155-171, 2025. e-Pub 2025. PMID: 40466852.
      7. Rodriques A, Liu G, Katchman A, Zakharov S, Wan E, Kalocsay M, Eisert R, Bradshaw GA, Chen BX, Yang L, Reiken S, Lai X, Ji R, Saadallah N, Topkara V, Fanourakis S, Yuan Q, Kushner J. Probing the Ca(V)1.2 interactome in heart failure identifies a positive modulator of inotropy and lusitropy. bioRxiv, 2025. e-Pub 2025. PMID: 40463082.
      8. Gui F, Jiang B, Jiang J, He Z, Tsujino T, Takai T, Arai S, Pana C, Köllermann J, Bradshaw GA, Eisert R, Kalocsay M, Fassl A, Balk SP, Kibel AS, Jia L. Acute BRCAness induction and AR pathway blockage through CDK12/7/9 degradation enhances PARP inhibitor sensitivity in prostate cancer. Science Advances 11(17), 2025. e-Pub 2025. PMID: 40267193.
      9. Vidović D, Shamsaei B, Schürer SC, Kogan P, Chojnacki S, Kouril M, Medvedovic M, Niu W, Azeloglu EU, Birtwistle MR, Chen Y, Chen T, Hansen J, Hu B, Iyengar R, Jayaraman G, Li H, Liu T, Sobie EA, Xiong Y, Berberich MJ, Bradshaw G, Chung M, Everley RA, Gaudio B, Hafner M, Kalocsay M, Mills CE, Nariya MK, Sorger PK, Subramanian K, Victor C, Banuelos M, Dardov V, Holewinski R, Manalo D, Mandefro B, Matlock AD, Ornelas L, Sareen D, Svendsen CN, Vaibhav V, Van Eyk JE, Venkatraman V, Finkbiener S, Fraenkel E, Rothstein J, Thompson L, Asiedu J, Carr SA, Christianson KE, Davison D, Dele-Oni DO, DeRuff KC, Egri SB, Vaca Jacome AS, Jaffe JD, Lam D, Litichevskiy L, Lu X, Mullahoo J, Officer A, Papanastasiou M, Peckner R, Toder C, Blanchard J, Bula M, Ko T, Tsai L, Young JZ, Sharma V, Pillai A, Meller J, MacCoss MJ. Comprehensive proteomics metadata and integrative web portals facilitate sharing and integration of LINCS multiomics data. Mol Cell Proteomics 24(7), 2025. e-Pub 2025. PMID: 40089066.
      10. Marx DC, Gonzalez-Hernandez AJ, Huynh K, Strauss A, Rico C, Siepe D, Gallo P, Lee J, Sharghi S, Arefin A, ProfileJohannes Broichhagen VO, Eliezer D, Kalocsay M, ProfileGeorge Khelashvili VO, Levitz J. Structural Diversity of Metabotropic Glutamate Receptor/Beta-Arrestin Coupling, 2025. PMID: 39975168.
      11. Deng X, Bradshaw G, Kalocsay M, Mitchison T. Tubulin Regulates the Stability and Localization of STMN2 by Binding Preferentially to Its Soluble Form. bioRxiv. e-Pub 2025. PMID: 40060442.
      12. Gallo, PN, Mihelc, E, Eisert, RJ, Bradshaw, GA, Dimek, F, Leffler, A, Kalocsay, M, Moiseenkova-Bell, V. The dynamic TRPV2 ion channel proximity proteome reveals functional links of calcium flux with cellular adhesion factors NCAM and L1CAM in neurite outgrowth. Cell Calcium 121, 2024. e-Pub 2024. PMID: 38728789.
      13. Susa KJ, Bradshaw GA, Eisert RJ, Schilling CM, Kalocsay M, Blacklow SC, Kruse AC. A spatiotemporal map of co-receptor signaling networks underlying B cell activation. Cell Rep 43(6):114332, 2024. e-Pub 2024. PMID: 38850533.
      14. Konig LE, Rodriguez S, Hug C, Daneshvari S, Chung A, Bradshaw GA, Sahin A, Zhou G, Eisert RJ, Piccioni F, Das S, Kalocsay M, Sokolov A, Sorger P, Root DE, Albers MW. TYK2 as a novel therapeutic target in Alzheimer's Disease with TDP-43 inclusions. bioRxiv, 2024. e-Pub 2024. PMID: 38895380.
      15. Deng X, Seguinot BO, Bradshaw G, Lee JS, Coy S, Kalocsay M, Santagata S, Mitchison T. STMND1 is a phylogenetically ancient stathmin which localizes to motile cilia and exhibits nuclear translocation that is inhibited when soluble tubulin concentration increases. Mol Biol Cell 35(6):ar82, 2024. e-Pub 2024. PMID: 38630521.
      16. Kalocsay M, Berberich MJ, Everley RA, Nariya MK, Chung M, Gaudio B, Victor C, Bradshaw GA, Eisert RJ, Hafner M, Sorger PK, Mills CE, Subramanian K. Proteomic profiling across breast cancer cell lines and models. Sci Data 10(1):514, 2023. e-Pub 2023. PMID: 37542042.
      17. Martin AP, Bradshaw GA, Eisert RJ, Egan ED, Tveriakhina L, Rogers JM, Dates AN, Scanavachi G, Aster JC, Kirchhausen T, Kalocsay M, Blacklow SC. A spatiotemporal Notch interaction map from plasma membrane to nucleus. Sci Signal 16(796):eadg6474, 2023. e-Pub 2023. PMID: 37527352.
      18. Zhou M, Fang R, Colson L, Donovan KA, Hunkeler M, Song Y, Zhang C, Chen S, Lee DH, Bradshaw GA, Eisert R, Ye Y, Kalocsay M, Goldberg A, Fischer ES, Lu Y. HUWE1 Amplifies Ubiquitin Modifications to Broadly Stimulate Clearance of Proteins and Aggregates. bioRxiv, 2023. e-Pub 2023. PMID: 37398461.
      19. Susa KJ, Bradshaw GA, Eisert RJ, Schilling CM, Kalocsay M, Blacklow SC, Kruse AC. A Spatiotemporal Map of Co-Receptor Signaling Networks Underlying B Cell Activation. bioRxiv, 2023. e-Pub 2023. PMID: 36993395.
      20. Papa A, Zakharov SI, Katchman AN, Kushner JS, Chen BX, Yang L, Liu G, Jimenez AS, Eisert RJ, Bradshaw GA, Dun W, Ali SR, Rodriques A, Zhou K, Topkara V, Yang M, Morrow JP, Tsai EJ, Karlin A, Wan E, Kalocsay M, Pitt GS, Colecraft HM, Ben-Johny M, Marx SO. Rad regulation of Ca(V)1.2 channels controls cardiac fight-or-flight response. Nat Cardiovasc Res 1(11):1022-1038, 2022. e-Pub 2022. PMID: 36424916.
      21. Fraser CS, Spetz JKE, Qin X, Presser A, Choiniere J, Li C, Yu S, Blevins F, Hata AN, Miller JW, Bradshaw GA, Kalocsay M, Sanchorawala V, Sarosiek S, Sarosiek KA. Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics. Nat Commun 13(1):5789, 2022. e-Pub 2022. PMID: 36184661.
      22. Zhou H, Stein CB, Shafiq TA, Shipkovenska G, Kalocsay M, Paulo JA, Zhang J, Luo Z, Gygi SP, Adelman K, Moazed D. Rixosomal RNA degradation contributes to silencing of Polycomb target genes. Nature 604(7904):167-174, 2022. e-Pub 2022. PMID: 35355014.
      23. Jimenez A, Lu D, Kalocsay M, Berberich MJ, Balbi P, Jambhekar A, Lahav G. Time-series transcriptomics and proteomics reveal alternative modes to decode p53 oscillations. Mol Syst Biol 18(3):e10588, 2022. e-Pub 2022. PMID: 35285572.
      24. Li L, Galichon P, Xiao X, Figueroa-Ramirez AC, Tamayo D, Lee JJ, Kalocsay M, Gonzalez-Sanchez D, Chancay MS, McCracken KW, Lee NN, Ichimura T, Mori Y, Valerius MT, Wilflingseder J, Lemos DR, Edelman ER, Bonventre JV. Orphan nuclear receptor COUP-TFII enhances myofibroblast glycolysis leading to kidney fibrosis. EMBO Rep 22(6):e51169, 2021. e-Pub 2021. PMID: 34031962.
      25. Jiang B, Gao Y, Che J, Lu W, Kaltheuner IH, Dries R, Kalocsay M, Berberich MJ, Jiang J, You I, Kwiatkowski N, Riching KM, Daniels DL, Sorger PK, Geyer M, Zhang T, Gray NS. Discovery and resistance mechanism of a selective CDK12 degrader. Nat Chem Biol 17(6):675-683, 2021. e-Pub 2021. PMID: 33753926.
      26. May EA, Kalocsay M, D'Auriac IG, Schuster PS, Gygi SP, Nachury MV, Mick DU. Time-resolved proteomics profiling of the ciliary Hedgehog response. J Cell Biol 220(5), 2021. e-Pub 2021. PMID: 33856408.
      27. Drouin A, Wallbillich N, Theberge M, Liu S, Katz J, Bellovoda K, Se Yun Cheon S, Gootkind F, Bierman E, Zavras J, Berberich MJ, Kalocsay M, Guastaldi F, Salvadori N, Troulis M, Fusco DN. Impact of Zika virus on the human type I interferon osteoimmune response. Cytokine 137:155342, 2021. e-Pub 2021. PMID: 33130337.
      28. Mehta AK, Cheney EM, Hartl CA, Pantelidou C, Oliwa M, Castrillon JA, Lin JR, Hurst KE, de Oliveira Taveira M, Johnson NT, Oldham WM, Kalocsay M, Berberich MJ, Boswell SA, Kothari A, Johnson S, Dillon DA, Lipschitz M, Rodig S, Santagata S, Garber JE, Tung N, Yélamos J, Thaxton JE, Mittendorf EA, Sorger PK, Shapiro GI, Guerriero JL. Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer. Nat Cancer 2(1):66-82, 2021. e-Pub 2021. PMID: 33738458.
      29. Shipkovenska G, Durango A, Kalocsay M, Gygi SP, Moazed D. A conserved RNA degradation complex required for spreading and epigenetic inheritance of heterochromatin. Elife 9, 2020. e-Pub 2020. PMID: 32491985.
      30. Santoriello C, Sporrij A, Yang S, Flynn RA, Henriques T, Dorjsuren B, Custo Greig E, McCall W, Stanhope ME, Fazio M, Superdock M, Lichtig A, Adatto I, Abraham BJ, Kalocsay M, Jurynec M, Zhou Y, Adelman K, Calo E, Zon LI. RNA helicase DDX21 mediates nucleotide stress responses in neural crest and melanoma cells. Nat Cell Biol 22(4):372-379, 2020. e-Pub 2020. PMID: 32231306.
      31. Nusinow DP, Szpyt J, Ghandi M, Rose CM, McDonald ER, Kalocsay M, Jané-Valbuena J, Gelfand E, Schweppe DK, Jedrychowski M, Golji J, Porter DA, Rejtar T, Wang YK, Kryukov GV, Stegmeier F, Erickson BK, Garraway LA, Sellers WR, Gygi SP. Quantitative Proteomics of the Cancer Cell Line Encyclopedia. Cell 180(2):387-402.e16, 2020. e-Pub 2020. PMID: 31978347.
      32. Pan J, Qian X, Lattmann S, El Sahili A, Yeo TH, Jia H, Cressey T, Ludeke B, Noton S, Kalocsay M, Fearns R, Lescar J. Structure of the human metapneumovirus polymerase phosphoprotein complex. Nature 577(7789):275-279, 2020. e-Pub 2020. PMID: 31698413.
      33. Mugahid D, Kalocsay M, Liu X, Gruver JS, Peshkin L, Kirschner MW. YAP regulates cell size and growth dynamics via non-cell autonomous mediators. Elife 9, 2020. e-Pub 2020. PMID: 31913124.
      34. Liu G, Papa A, Katchman AN, Zakharov SI, Roybal D, Hennessey JA, Kushner J, Yang L, Chen BX, Kushnir A, Dangas K, Gygi SP, Pitt GS, Colecraft HM, Ben-Johny M, Kalocsay M, Marx SO. Mechanism of adrenergic CaV1.2 stimulation revealed by proximity proteomics. Nature 577(7792):695-700, 2020. e-Pub 2020. PMID: 31969708.
      35. Wang Y, Dix MM, Bianco G, Remsberg JR, Lee HY, Kalocsay M, Gygi SP, Forli S, Vite G, Lawrence RM, Parker CG, Cravatt BF. Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs. Nat Chem 11(12):1113-1123, 2019. e-Pub 2019. PMID: 31659311.
      36. Ferguson FM, Doctor ZM, Ficarro SB, Browne CM, Marto JA, Johnson JL, Yaron TM, Cantley LC, Kim ND, Sim T, Berberich MJ, Kalocsay M, Sorger PK, Gray NS. Discovery of Covalent CDK14 Inhibitors with Pan-TAIRE Family Specificity. Cell Chem Biol 26(6):804-817.e12, 2019. e-Pub 2019. PMID: 30930164.
      37. Kalocsay M. APEX Peroxidase-Catalyzed Proximity Labeling and Multiplexed Quantitative Proteomics. Methods Mol Biol 2008:41-55, 2019. e-Pub 2019. PMID: 31124087.
      38. Iglesias N, Currie MA, Jih G, Paulo JA, Siuti N, Kalocsay M, Gygi SP, Moazed D. Automethylation-induced conformational switch in Clr4 (Suv39h) maintains epigenetic stability. Nature 560(7719):504-508, 2018. e-Pub 2018. PMID: 30051891.
      39. Brumbaugh J, Di Stefano B, Wang X, Borkent M, Forouzmand E, Clowers KJ, Ji F, Schwarz BA, Kalocsay M, Elledge SJ, Chen Y, Sadreyev RI, Gygi SP, Hu G, Shi Y, Hochedlinger K. Nudt21 Controls Cell Fate by Connecting Alternative Polyadenylation to Chromatin Signaling. Cell 172(1-2):106-120.e21, 2018. e-Pub 2018. PMID: 29249356.
      40. Paek J, Kalocsay M, Staus DP, Wingler L, Pascolutti R, Paulo JA, Gygi SP, Kruse AC. Multidimensional Tracking of GPCR Signaling via Peroxidase-Catalyzed Proximity Labeling. Cell 169(2):338-349.e11, 2017. e-Pub 2017. PMID: 28388415.
      41. Renkawitz J, Lademann CA, Kalocsay M, Jentsch S. Monitoring homology search during DNA double-strand break repair in vivo. Mol Cell 50(2):261-72, 2013. e-Pub 2013. PMID: 23523370.
      42. Kalocsay M, Hiller NJ, Jentsch S. Chromosome-wide Rad51 spreading and SUMO-H2A.Z-dependent chromosome fixation in response to a persistent DNA double-strand break. Mol Cell 33(3):335-43, 2009. e-Pub 2009. PMID: 19217407.
      43. Jasiak AJ, Hartmann H, Karakasili E, Kalocsay M, Flatley A, Kremmer E, Strasser K, Martin DE, Soding J, Cramer P. Genome-associated RNA polymerase II includes the dissociable Rpb4/7 subcomplex. J Biol Chem 283(39):26423-7, 2008. e-Pub 2008. PMID: 18667430.
      44. Rape M, Hoppe T, Gorr I, Kalocay M, Richly H, Jentsch S. Mobilization of processed, membrane-tethered SPT23 transcription factor by CDC48(UFD1/NPL4), a ubiquitin-selective chaperone. Cell 107(5):667-77, 2001. e-Pub 2001. PMID: 11733065.

      Review Articles

      1. Kushner JS, Liu G, Eisert RJ, Bradshaw GA, Pitt GS, Hinson JT, Kalocsay M, Marx SO. Detecting Cardiovascular Protein-Protein Interactions by Proximity Proteomics. Circ Res 130(2):273-287, 2022. e-Pub 2022. PMID: 35050691.

      Other Articles

      1. Vidović, D, Shamsaei, B, Schürer, S, Kogan, P, Chojnacki, S, Kouril, M, Medvedovic, M, Niu, W, Azeloglu, EU, Birtwistle, MR, Chen, Y, Chen, T, Hansen, J, Hu, B, Iyengar, R, Jayaraman, G, Li, H, Liu, T, Sobie, EA, Xiong, Y, Berberich, MJ, Bradshaw, GA, Chung, M, Everley, RA, Gaudio, B, Hafner, M, Kalocsay, M, Mills, CE, Nariya, MK, Sorger, PK, Subramanian, K, Victor, C, Banuelos, M, Dardov, V, Holewinski, R, Manalo, DM, Mandefro, B, Matlock, A, Ornelas, L, Sareen, D, Svendsen, CN, Vaibhav, V, van Eyk, JE, Venkatraman, V, Finkbiener, S, Fraenkel, E, Rothstein, JD, Thompson, L, Asiedu, J, Carr, SA, Christianson, KE, Davison, D, Dele-Oni, DO, DeRuff, KC, Egri, SB, Vaca Jacome, AS, Jaffe, JD, Lam, D, Litichevskiy, L, Lu, X, Mullahoo, J, Officer, A, Papanastasiou, M, Peckner, R, Toder, C, Blanchard, J, Bula, M, Ko, T, Tsai, LH, Young, JZ, Sharma, V, Meller, J, MacCoss, MJ Corrigendum to "Comprehensive Proteomics Metadata and Integrative Web Portals Facilitate Sharing and Integration of LINCS Multiomics Data". Molecular and Cellular Proteomics 24(7):100995, 2025. PMID: 40783300.
      2. Brumbaugh J, Di Stefano B, Wang X, Borkent M, Forouzmand E, Clowers KJ, Ji F, Schwarz BA, Kalocsay M, Elledge SJ, Chen Y, Sadreyev RI, Gygi SP, Hu G, Shi Y, Hochedlinger K Nudt21 Controls Cell Fate by Connecting Alternative Polyadenylation to Chromatin Signaling. Cell 172(3):629-631, 2018. PMID: 29373832.

      Patents

      1. Marx SO, Kushnir A, Zakharov S, Katchman A, Gygi SP, Kalocsay M, Manu B, Colecraft HM, Guoxia LIU. Novel approach for increasing contractility in patients with systolic heart failure. Patent Number: 17624497.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Kalocsay Laboratory

      • Experimental Radiation Oncology department

      • Radiation Oncology division

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top